Focus: Aluna develops asthma tracking devices positioned in the respiratory care market, leveraging digital health to enable real-time disease monitoring.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Aluna to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Help build intelligence for Aluna
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Aluna's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Draft genome sequence of Pseudomonas aeruginosa Pa047c, a pan-resistant strain isolated from an ICU in Manaus, Amazonas.
[The technoscientific production of zika virus and zika disease: risks and insecurity in the health field].
Investigating the effects of synbiotics, postbiotics and bacilli in the modulation of gut microbiota and the survival of Litopenaeus vannamei challenged with Vibrio parahaemolyticus.
Detection of SO(2) using a hybrid LDH-MOF material.
Assessment of 3 standards-based clinical decision support (CDS) tools in an academic electronic health record using Clinical Quality Language, CDS Hooks, and Fast Healthcare Interoperability Resources: a retrospective evaluation.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo